Melanotan I vs Melanotan II: Comparative Melanocortin Receptor Pharmacology Research

Melanotan I vs Melanotan II: Comparative Melanocortin Receptor Pharmacology Research In vitro research overview of Melanotan broad melanocortin receptor (MC1R in cell-based assay systems. For laboratory research use only. Melanotan I vs Melanotan II: Comparative Melanocortin Receptor Pharmacology Research Melanotan peptides represent synthetic analogs of α-melanocyte stimulating hormone (α-MSH) extensively studied in cell-based assay formats for their melanocortin receptor binding properties. Published in vitro research characterizes their molecular interactions, binding affinity profiles, and downstream pathway engagement in defined cell model systems under controlled laboratory conditions. These peptides demonstrate distinct pharmacological profiles across melanocortin receptor subtypes, making them valuable research tools for investigating melanocortin signaling pathways. Receptor Pharmacology and Mechanism of Action Melanotan I (Afamelanotide) Receptor Profile Melanotan I exhibits selective binding affinity for melanocortin-1 receptor (MC1R) with documented EC50 values ranging from 0.1-1.0 nM in transfected cell models. In vitro assays demonstrate high specificity for MC1R compared to other melanocortin receptor subtypes. The peptide demonstrates competitive binding characteristics in radioligand displacement studies, effectively competing with endogenous α-MSH for receptor occupancy. Cell-based cAMP accumulation assays reveal potent adenylyl cyclase activation following MC1R binding. Melanotan I demonstrates full agonist activity with maximal cAMP responses reaching 85-95% of forskolin-stimulated levels in MC1R-expressing cell lines. The peptide exhibits a steep dose-response curve characteristic of high-affinity receptor interactions. Melanotan II Pan-Melanocortin Activity Melanotan II demonstrates broader melanocortin receptor pharmacology with significant binding affinity across MC1R, MC3R, MC4R, and MC5R subtypes. In vitro binding studies reveal EC50 values of 0.3 nM (MC1R), 2.1 nM (MC3R), 1.1 nM (MC4R), and 2.8 nM (MC5R) in respective transfected cell models. This pan-melanocortin activity distinguishes Melanotan II from the MC1R-selective profile of Melanotan I. Functional assays demonstrate robust cAMP signaling activation across multiple receptor subtypes. MC4R-expressing cell lines show particularly strong responses to Melanotan II stimulation, with cAMP accumulation reaching maximal levels at nanomolar concentrations. G-protein coupling efficiency studies indicate optimal Gs-adenylyl cyclase pathway activation across the melanocortin receptor family. Comparative Binding Kinetics and Signaling Pathways Binding Affinity Analysis Competitive binding assays reveal distinct kinetic profiles between Melanotan peptides. Melanotan I demonstrates slower association rates (kon = 2.1 × 10^6 M^-1s^-1) but significantly slower dissociation kinetics (koff = 0.08 s^-1) at MC1R, resulting in extended receptor occupancy duration. Surface plasmon resonance studies confirm high-affinity binding with KD values consistently below 1 nM. Melanotan II exhibits faster association kinetics across melanocortin receptors but demonstrates more rapid dissociation rates. MC4R bin